Inovio Pharmaceuticals has reported promising initial data from its first Phase III study of its electrical current-driven DNA plasmid-based immunotherapy, VGX-3100, in virus-associated cervical dysplasia; it is heading a small group of companies evaluating novel therapies in the condition, which often advances to cancer.

Information Services; Decision support for hospitals and HMOs. HealthShare can provide hospitals and managed care organizations with data that compares named hospitalsin terms of their cost, quality and market positions. It has also developed patented software that creates computer-generated management reports for health care executives or clinicians.

Colorectal cancer screening.